Advancing glioblastoma treatment by targeting metabolism

Alterations in cellular metabolism are important hallmarks of glioblastoma(GBM). Metabolic reprogramming is a critical feature as it meets the higher nutritional demand of tumor cells, including proliferation, growth, and survival. Many genes, proteins, and metabolites associated with GBM metabolism...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neoplasia (New York, N.Y.) Ročník 51; s. 100985
Hlavní autoři: Zhao, Jinyi, Ma, Xuemei, Gao, Peixian, Han, Xueqi, Zhao, Pengxiang, Xie, Fei, Liu, Mengyu
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Elsevier Inc 01.05.2024
Neoplasia Press
Elsevier
Témata:
ISSN:1476-5586, 1522-8002, 1476-5586
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Alterations in cellular metabolism are important hallmarks of glioblastoma(GBM). Metabolic reprogramming is a critical feature as it meets the higher nutritional demand of tumor cells, including proliferation, growth, and survival. Many genes, proteins, and metabolites associated with GBM metabolism reprogramming have been found to be aberrantly expressed, which may provide potential targets for cancer treatment. Therefore, it is becoming increasingly important to explore the role of internal and external factors in metabolic regulation in order to identify more precise therapeutic targets and diagnostic markers for GBM. In this review, we define the metabolic characteristics of GBM, investigate metabolic specificities such as targetable vulnerabilities and therapeutic resistance, as well as present current efforts to target GBM metabolism to improve the standard of care.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1476-5586
1522-8002
1476-5586
DOI:10.1016/j.neo.2024.100985